Company profile PALI
After 39 days of this quarter the interest is at 153.0. Based on that we can calculate that during remaining 52 days it will total up to 357.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 49 | 0 -100.0% QoQ | 94 inf% QoQ | 107 13.8% QoQ |
| 2020 | 64 30.6% YoY -40.2% QoQ | 18 inf% YoY -71.9% QoQ | 33 -64.9% YoY 83.3% QoQ | 161 50.5% YoY 387.9% QoQ |
| 2021 | 298 365.6% YoY 85.1% QoQ | 280 1455.6% YoY -6.0% QoQ | 316 857.6% YoY 12.9% QoQ | 151 -6.2% YoY -52.2% QoQ |
| 2022 | 384 28.9% YoY 154.3% QoQ | 222 -20.7% YoY -42.2% QoQ | 344 8.9% YoY 55.0% QoQ | 361 139.1% YoY 4.9% QoQ |
| 2023 | 274 -28.6% YoY -24.1% QoQ | 295 32.9% YoY 7.7% QoQ | 283 -17.7% YoY -4.1% QoQ | 275 -23.8% YoY -2.8% QoQ |
| 2024 | 153 -44.2% YoY -44.4% QoQ | - | - | - |
The average 5 years interest of Palisade Bio was 15.95 per week. The last year interest of Palisade Bio compared to the last 5 years has changed by 36.49%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 314.67%.
There is not enough data for Palisade Bio LB1148 to provide analysis
There is not enough data for Palisade Bio LB1148 to provide correlation calculation
There is not enough data for Palisade Bio LB1148 to provide analysis
There is not enough data for digestive enzyme inhibitor to provide analysis
There is not enough data for digestive enzyme inhibitor to provide correlation calculation
There is not enough data for digestive enzyme inhibitor to provide analysis
After 39 days of this quarter the interest is at 414.0. Based on that we can calculate that during remaining 52 days it will total up to 966.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 267 | 498 86.5% QoQ | 475 -4.6% QoQ | 490 3.2% QoQ |
| 2020 | 470 76.0% YoY -4.1% QoQ | 466 -6.4% YoY -0.9% QoQ | 582 22.5% YoY 24.9% QoQ | 574 17.1% YoY -1.4% QoQ |
| 2021 | 672 43.0% YoY 17.1% QoQ | 742 59.2% YoY 10.4% QoQ | 671 15.3% YoY -9.6% QoQ | 613 6.8% YoY -8.6% QoQ |
| 2022 | 897 33.5% YoY 46.3% QoQ | 901 21.4% YoY 0.4% QoQ | 879 31.0% YoY -2.4% QoQ | 819 33.6% YoY -6.8% QoQ |
| 2023 | 1043 16.3% YoY 27.4% QoQ | 1156 28.3% YoY 10.8% QoQ | 1108 26.1% YoY -4.2% QoQ | 1107 35.2% YoY -0.1% QoQ |
| 2024 | 414 -60.3% YoY -62.6% QoQ | - | - | - |
The average 5 years interest of tranexamic acid was 56.87 per week. The last year interest of tranexamic acid compared to the last 5 years has changed by 48.76%. The interest for tranexamic acid is trending. The last year interest is quite higher compared to 5 years ago. It has increased by 129.45%.
There is not enough data for postoperative adhesions to provide analysis
There is not enough data for postoperative adhesions to provide correlation calculation
There is not enough data for postoperative adhesions to provide analysis
After 39 days of this quarter the interest is at 144.0. Based on that we can calculate that during remaining 52 days it will total up to 336.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 127 | 367 189.0% QoQ | 468 27.5% QoQ | 394 -15.8% QoQ |
| 2020 | 380 199.2% YoY -3.6% QoQ | 248 -32.4% YoY -34.7% QoQ | 391 -16.5% YoY 57.7% QoQ | 521 32.2% YoY 33.2% QoQ |
| 2021 | 391 2.9% YoY -25.0% QoQ | 423 70.6% YoY 8.2% QoQ | 425 8.7% YoY 0.5% QoQ | 378 -27.4% YoY -11.1% QoQ |
| 2022 | 514 31.5% YoY 36.0% QoQ | 327 -22.7% YoY -36.4% QoQ | 262 -38.4% YoY -19.9% QoQ | 495 31.0% YoY 88.9% QoQ |
| 2023 | 421 -18.1% YoY -14.9% QoQ | 529 61.8% YoY 25.7% QoQ | 412 57.3% YoY -22.1% QoQ | 310 -37.4% YoY -24.8% QoQ |
| 2024 | 144 -65.8% YoY -53.5% QoQ | - | - | - |
The average 5 years interest of postoperative ileus was 30.37 per week. The last year interest of postoperative ileus compared to the last 5 years has changed by 2.27%. The interest for postoperative ileus is seasonal. The last year interest is comparable to 5 years ago. It has changed only by 4.19%.
There is not enough data for return of bowel function to provide analysis
There is not enough data for return of bowel function to provide correlation calculation
There is not enough data for return of bowel function to provide analysis
There is not enough data for clinical-stage biopharmaceutical company to provide analysis
There is not enough data for clinical-stage biopharmaceutical company to provide correlation calculation
There is not enough data for clinical-stage biopharmaceutical company to provide analysis
There is not enough data for intestinal barrier protection to provide analysis
There is not enough data for intestinal barrier protection to provide correlation calculation
There is not enough data for intestinal barrier protection to provide analysis
After 39 days of this quarter the interest is at 214.0. Based on that we can calculate that during remaining 52 days it will total up to 499.0. healthcare biotechnology expected interest is significantly higher compared to previous quarter (+86.9%) and same quarter last year (+70.3%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 139 | 169 21.6% QoQ | 156 -7.7% QoQ | 160 2.6% QoQ |
| 2020 | 238 71.2% YoY 48.8% QoQ | 288 70.4% YoY 21.0% QoQ | 245 57.1% YoY -14.9% QoQ | 217 35.6% YoY -11.4% QoQ |
| 2021 | 170 -28.6% YoY -21.7% QoQ | 145 -49.7% YoY -14.7% QoQ | 219 -10.6% YoY 51.0% QoQ | 178 -18.0% YoY -18.7% QoQ |
| 2022 | 198 16.5% YoY 11.2% QoQ | 353 143.4% YoY 78.3% QoQ | 330 50.7% YoY -6.5% QoQ | 226 27.0% YoY -31.5% QoQ |
| 2023 | 293 48.0% YoY 29.6% QoQ | 336 -4.8% YoY 14.7% QoQ | 420 27.3% YoY 25.0% QoQ | 267 18.1% YoY -36.4% QoQ |
| 2024 | 214 -27.0% YoY -19.9% QoQ | - | - | - |
The average 5 years interest of healthcare biotechnology was 19.01 per week. The last year interest of healthcare biotechnology compared to the last 5 years has changed by 36.35%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 97.56%.
There is not enough data for Palisade Bio CEO to provide analysis
There is not enough data for Palisade Bio CEO to provide correlation calculation
There is not enough data for Palisade Bio CEO to provide analysis
There is not enough data for Palisade Bio Chief Medical Officer to provide analysis
There is not enough data for Palisade Bio Chief Medical Officer to provide correlation calculation
There is not enough data for Palisade Bio Chief Medical Officer to provide analysis
There is not enough data for Palisade Bio VP of Finance to provide analysis
There is not enough data for Palisade Bio VP of Finance to provide correlation calculation
There is not enough data for Palisade Bio VP of Finance to provide analysis
There is not enough data for Palisade Bio corporate governance to provide analysis
There is not enough data for Palisade Bio corporate governance to provide correlation calculation
There is not enough data for Palisade Bio corporate governance to provide analysis